Description
JUPIPAC-260
Paclitaxel 260 mg Injection
The first microtubule targeting agent
Broad activity in several cancers including:
Breast, Ovarian, Cervical, Endometrial, Bladder, Lung, Prostatic, Melanoma, Esophageal, Kaposi Sarcoma, Other solid Tumors
